For the quarter ending 2025-09-30, ZOMDF had -$619K decrease in cash & cash equivalents over the period. -$4,703K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -6,121 | -71,207 |
| Depreciation | 506 | 1,030 |
| Amortization - intangible assets | 1,394 | 3,105 |
| Impairment loss | 0 | 55,833 |
| Loss on disposal of property and equipment | -36 | -7 |
| Stock-based compensation | 867 | 878 |
| Noncash portion of rent benefit | -10 | -21 |
| Accretion/amortization of available-for-sale securities | 141 | 476 |
| Equity in loss of nonconsolidated entities | -13 | -80 |
| Deferred tax expense | -47 | -112 |
| Purchased inventory | -121 | 672 |
| Prepaid expenses and deposits | 468 | -373 |
| Trade receivables | 847 | -126 |
| Other receivables | -192 | -174 |
| Accounts payable | -420 | 275 |
| Accrued income tax | -58 | -8 |
| Accrued expenses and other current liabilities | 321 | -1,578 |
| Customer contract liabilities | -8 | 47 |
| Other liabilities | 10 | 56 |
| Net cash used in operating activities | -4,660 | -12,090 |
| Securities matured | -4,185 | -13,700 |
| Investment in property and equipment | 43 | 417 |
| Acquisition of intangibles | 101 | 198 |
| Net cash provided by investing activities | 4,041 | 13,085 |
| Increase (decrease) in cash and cash equivalents | -619 | 995 |
| Effect of exchange rate changes on cash | 99 | - |
| Cash and cash equivalents at beginning of period | 7,021 | - |
| Cash and cash equivalents at end of period | 7,496 | - |
Zomedica Corp. (ZOMDF)
Zomedica Corp. (ZOMDF)